NO971517L - Peptider og farmasöytiske sammensetninger omfattende dem - Google Patents

Peptider og farmasöytiske sammensetninger omfattende dem

Info

Publication number
NO971517L
NO971517L NO971517A NO971517A NO971517L NO 971517 L NO971517 L NO 971517L NO 971517 A NO971517 A NO 971517A NO 971517 A NO971517 A NO 971517A NO 971517 L NO971517 L NO 971517L
Authority
NO
Norway
Prior art keywords
cells
peptides
pharmaceutical compositions
idiotypic
activity
Prior art date
Application number
NO971517A
Other languages
English (en)
Norwegian (no)
Other versions
NO971517D0 (no
Inventor
Irun I Cohen
Dana Elias
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO971517D0 publication Critical patent/NO971517D0/no
Publication of NO971517L publication Critical patent/NO971517L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO971517A 1994-10-07 1997-04-03 Peptider og farmasöytiske sammensetninger omfattende dem NO971517L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11119694A IL111196A0 (en) 1994-10-07 1994-10-07 Peptides and pharmaceutical compositions comprising them
PCT/US1995/012686 WO1996011214A1 (en) 1994-10-07 1995-10-10 Peptides and pharmaceutical compositions comprising them

Publications (2)

Publication Number Publication Date
NO971517D0 NO971517D0 (no) 1997-04-03
NO971517L true NO971517L (no) 1997-05-22

Family

ID=11066614

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971517A NO971517L (no) 1994-10-07 1997-04-03 Peptider og farmasöytiske sammensetninger omfattende dem

Country Status (15)

Country Link
EP (1) EP0783524B1 (de)
JP (1) JPH10507345A (de)
KR (1) KR100381711B1 (de)
AT (1) ATE289611T1 (de)
AU (1) AU708301B2 (de)
CA (1) CA2201935A1 (de)
CZ (1) CZ103197A3 (de)
DE (1) DE69534024T2 (de)
FI (1) FI971427A7 (de)
HU (1) HUT77484A (de)
IL (1) IL111196A0 (de)
NO (1) NO971517L (de)
PL (1) PL319831A1 (de)
SK (1) SK44197A3 (de)
WO (1) WO1996011214A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716963B1 (en) 1998-05-22 2004-04-06 Abbott Laboratories Peptide antiangiogenic drugs
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US7488590B2 (en) 1998-10-23 2009-02-10 Amgen Inc. Modified peptides as therapeutic agents
ATE348163T1 (de) 1998-10-23 2007-01-15 Amgen Inc Thrombopoietin substitute
EP1773400A2 (de) 2004-07-08 2007-04-18 Amgen Inc. Therapeutische peptide
CA2580796C (en) 2004-09-24 2013-03-26 Amgen Inc. Modified fc molecules having peptides inserted in internal loop regions
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
EP3122768A2 (de) * 2014-03-27 2017-02-01 Yeda Research and Development Co. Ltd. T-zell-rezeptor-cdr3-peptide und -antikörper
EP4011910A1 (de) 2014-04-03 2022-06-15 IGM Biosciences, Inc. Modifizierte j-kette
ES2819870T3 (es) 2015-09-30 2021-04-19 Igm Biosciences Inc Moléculas de unión con cadena J modificada
PT3355913T (pt) 2015-09-30 2024-12-18 Igm Biosciences Inc Moléculas de ligação com cadeia j modificada
CN120699093B (zh) * 2025-06-26 2026-04-14 华中农业大学 一种蛋黄源降血糖肽及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886743A (en) * 1985-04-24 1989-12-12 California Institute Of Technology Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof

Also Published As

Publication number Publication date
JPH10507345A (ja) 1998-07-21
KR970706306A (ko) 1997-11-03
ATE289611T1 (de) 2005-03-15
DE69534024T2 (de) 2006-01-12
AU708301B2 (en) 1999-07-29
FI971427L (fi) 1997-05-26
AU3946295A (en) 1996-05-02
HUT77484A (hu) 1998-05-28
EP0783524A1 (de) 1997-07-16
SK44197A3 (en) 1997-11-05
FI971427A7 (fi) 1997-05-26
PL319831A1 (en) 1997-09-01
FI971427A0 (fi) 1997-04-04
DE69534024D1 (de) 2005-03-31
NO971517D0 (no) 1997-04-03
CZ103197A3 (en) 1997-09-17
KR100381711B1 (ko) 2003-07-16
IL111196A0 (en) 1994-12-29
EP0783524B1 (de) 2005-02-23
WO1996011214A1 (en) 1996-04-18
CA2201935A1 (en) 1996-04-18
EP0783524A4 (de) 2000-05-17

Similar Documents

Publication Publication Date Title
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
CA2219988A1 (en) Cd16-ii variants
NO930011L (no) Tilfeldig boi-oligomer bibilotek og fremgangsmaate for syntese og anvendelse derav
NO971517D0 (no) Peptider og farmasöytiske sammensetninger omfattende dem
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
ATE389724T1 (de) Menschliche dnase i hyperaktive varianten
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
IS4510A (is) Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki
HUP9901688A2 (hu) A diabétesz kezelésére szolgáló, humán hősokk protein 60-ból származó új peptidek, készítmények, eljárások és kitek
NO952385D0 (no) Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
HUP0004605A1 (hu) Presenilinek és a béta-amiloid peptid vagy prekurzora közötti kölcsönhatás gátlására képes peptidek
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE69738600D1 (de) Neuroaktive peptide
ATE183652T1 (de) Synthetische peptide für die behandlung von myasthenia gravis
NO964688L (no) Ny peptid-aktivsubstans og fremstilling av denne
DK0722460T3 (da) Peptidderivater der er terapeutisk aktive i blodkoaguleringskaskaden, fremgangsmåde til fremstilling heraf og farmaceutiske
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
NO900255L (no) Peptider med t-cellehjelperaktivitet.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application